Aer Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Aer Therapeutics?

Aer Therapeutics has 3 investors including Hatteras Venture Partners And Canaan Partners.

Q: When was the last funding round for Aer Therapeutics?

Aer Therapeutics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Aer Therapeutics raised to date?

Aer Therapeutics has raised obfuscated.

Overview

Aer Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Aer Therapeutics

CB Rank

43595

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Founded

obfuscation

Private

Venture - Series Unknown

Raleigh, North Carolina, United States

1-10

aertherapeutics.com/

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Key People

John Fahy: Founder

Details

Legal Name

Aer Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

John Fahy

About the Company

Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

AER-01

An inhaled small molecule mucolytic drug designed to liquefy mucus plugs in the lungs of patients with muco-obstructive lung diseases such as COPD and asthma.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Aer Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Hatteras Venture Partners	—	Series A - Aer Therapeutics	Christy L. Shaffer
Hatteras Venture Partners	—	Series A - Aer Therapeutics	Christy L. Shaffer
Hatteras Venture Partners	—	Series A - Aer Therapeutics	Christy L. Shaffer
Hatteras Venture Partners	—	Series A - Aer Therapeutics	Christy L. Shaffer
Hatteras Venture Partners	—	Series A - Aer Therapeutics	Christy L. Shaffer